Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Abramyan AM"'
Autor:
Hamlish NX; Department of Molecular and Cellular Biology, University of California, Berkeley, California 94720, United States., Abramyan AM; Schrödinger, Inc., San Diego, California 92121, United States., Shah B; Process Development, Attribute Sciences, Amgen Inc., Thousand Oaks, California 91320, United States., Zhang Z; Process Development, Attribute Sciences, Amgen Inc., Thousand Oaks, California 91320, United States., Schepartz A; Department of Molecular and Cellular Biology, University of California, Berkeley, California 94720, United States.; Department of Chemistry, University of California, Berkeley, Calfornia 94720, United States.; California Institute for Quantitative Biosciences, University of California, Berkeley, California 94720, United States.; Chan Zuckerberg Biohub, San Francisco, California 94158, United States.; ARC Institute, Palo Alto, California 94304, United States.
Publikováno v:
ACS central science [ACS Cent Sci] 2024 Apr 23; Vol. 10 (5), pp. 1044-1053. Date of Electronic Publication: 2024 Apr 23 (Print Publication: 2024).
Autor:
Salomon K; Laboratory for Membrane Protein Dynamics, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark., Abramyan AM; Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, NIH, Baltimore, MD 21224.; Schrödinger, Inc., San Diego, CA 92121., Plenge P; Laboratory for Membrane Protein Dynamics, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark., Wang L; Schrödinger, Inc., New York, NY 10036., Bundgaard C; Medicinal Chemistry and Translational DMPK, H. Lundbeck A/S, DK-2500 Copenhagen-Valby, Denmark., Bang-Andersen B; Medicinal Chemistry and Translational DMPK, H. Lundbeck A/S, DK-2500 Copenhagen-Valby, Denmark., Loland CJ; Laboratory for Membrane Protein Dynamics, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark., Shi L; Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, NIH, Baltimore, MD 21224.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Oct 10; Vol. 120 (41), pp. e2304089120. Date of Electronic Publication: 2023 Oct 04.
Autor:
Watson ZL; Department of Chemistry, University of California, Berkeley, CA, USA.; Center for Genetically Encoded Materials, University of California, Berkeley, CA, USA.; California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, CA, USA., Knudson IJ; Department of Chemistry, University of California, Berkeley, CA, USA.; Center for Genetically Encoded Materials, University of California, Berkeley, CA, USA., Ward FR; Center for Genetically Encoded Materials, University of California, Berkeley, CA, USA.; Department of Molecular and Cellular Biology, University of California, Berkeley, CA, USA., Miller SJ; Center for Genetically Encoded Materials, University of California, Berkeley, CA, USA. scott.miller@yale.edu.; Department of Chemistry, Yale University, New Haven, CT, USA. scott.miller@yale.edu., Cate JHD; Department of Chemistry, University of California, Berkeley, CA, USA. j-h-doudna-cate@berkeley.edu.; Center for Genetically Encoded Materials, University of California, Berkeley, CA, USA. j-h-doudna-cate@berkeley.edu.; Department of Molecular and Cellular Biology, University of California, Berkeley, CA, USA. j-h-doudna-cate@berkeley.edu.; Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA. j-h-doudna-cate@berkeley.edu., Schepartz A; Department of Chemistry, University of California, Berkeley, CA, USA. schepartz@berkeley.edu.; Center for Genetically Encoded Materials, University of California, Berkeley, CA, USA. schepartz@berkeley.edu.; California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, CA, USA. schepartz@berkeley.edu.; Department of Molecular and Cellular Biology, University of California, Berkeley, CA, USA. schepartz@berkeley.edu.; Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA. schepartz@berkeley.edu.; Chan Zuckerberg Biohub, San Francisco, CA, USA. schepartz@berkeley.edu., Abramyan AM; Schrödinger, Inc., San Diego, CA, USA. ara.abramyan@schrodinger.com.
Publikováno v:
Nature chemistry [Nat Chem] 2023 Jul; Vol. 15 (7), pp. 913-921. Date of Electronic Publication: 2023 Jun 12.
Autor:
Plenge P; Laboratory for Membrane Protein Dynamics. Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Abramyan AM; Computational Chemistry and Molecular Biophysics Unit, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Sørensen G; Lundbeck Research, H. Lundbeck A/S, Copenhagen, Denmark., Mørk A; Lundbeck Research, H. Lundbeck A/S, Copenhagen, Denmark., Weikop P; Laboratory of Neuropsychiatry, Psychiatric Centre Copenhagen, University of Copenhagen, Copenhagen, Denmark., Gether U; Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Bang-Andersen B; Lundbeck Research, H. Lundbeck A/S, Copenhagen, Denmark. BAN@Lundbeck.com.; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark. BAN@Lundbeck.com., Shi L; Computational Chemistry and Molecular Biophysics Unit, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, MD, USA. lei.shi2@nih.gov., Loland CJ; Laboratory for Membrane Protein Dynamics. Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. cllo@sund.ku.dk.
Publikováno v:
Nature communications [Nat Commun] 2020 Mar 20; Vol. 11 (1), pp. 1491. Date of Electronic Publication: 2020 Mar 20.
Autor:
Lane JR; Division of Pharmacology, Physiology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.; Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, United Kingdom., Abramyan AM; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, United States., Adhikari P; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, United States., Keen AC; Division of Pharmacology, Physiology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.; Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, United Kingdom.; Drug Discovery Biology, Department of Pharmacology and Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia., Lee KH; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, United States., Sanchez J; Division of Pharmacology, Physiology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.; Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, United Kingdom., Verma RK; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, United States., Lim HD; Drug Discovery Biology, Department of Pharmacology and Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia., Yano H; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, United States., Javitch JA; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, United States.; Department of Pharmacology, Vagelos College of Physicians and Surgeons, Columbia University, New York, United States., Shi L; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, United States.
Publikováno v:
ELife [Elife] 2020 Jan 27; Vol. 9. Date of Electronic Publication: 2020 Jan 27.
Autor:
Abramyan AM; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, MD, United States., Yano H; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, MD, United States., Xu M; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, MD, United States., Liu L; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, MD, United States., Naing S; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, MD, United States., Fant AD; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, MD, United States., Shi L; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, MD, United States.
Publikováno v:
Computational and structural biotechnology journal [Comput Struct Biotechnol J] 2020 Jan 07; Vol. 18, pp. 199-206. Date of Electronic Publication: 2020 Jan 07 (Print Publication: 2020).
Autor:
Abramyan AM; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, United States., Slack RD; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, United States., Meena S; Department of Cellular and Molecular Physiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06520, United States., Davis BA; Department of Cellular and Molecular Physiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06520, United States., Newman AH; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, United States. Electronic address: anewman@intra.nida.nih.gov., Singh SK; Department of Cellular and Molecular Physiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06520, United States. Electronic address: satinder.k.singh@yale.edu., Shi L; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, United States. Electronic address: lei.shi2@nih.gov.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2019 Dec 15; Vol. 161, pp. 107411. Date of Electronic Publication: 2018 Nov 01.
Autor:
Bonaventura J; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA., Eldridge MAG; Laboratory of Neuropsychology, National Institute of Mental Health Intramural Research Program, Bethesda, MD, 20892, USA., Hu F; Department of Radiology Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA., Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA., Sanchez-Soto M; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, MD, 20814, USA., Abramyan AM; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA., Lam S; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA., Boehm MA; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA., Ruiz C; Department of Neurobiology & Behavior, University of California, Irvine, CA, 92697, USA., Farrell MR; Department of Neurobiology & Behavior, University of California, Irvine, CA, 92697, USA., Moreno A; Department of Molecular Biology and Genetics, Dandrite, Aarhus University, 8000 Aarhus C, Aarhus, Denmark., Galal Faress IM; Department of Molecular Biology and Genetics, Dandrite, Aarhus University, 8000 Aarhus C, Aarhus, Denmark., Andersen N; Department of Molecular Biology and Genetics, Dandrite, Aarhus University, 8000 Aarhus C, Aarhus, Denmark., Lin JY; School of Medicine, College of Health and Medicine, University of Tasmania, Tasmania, TAS, 7000, Australia., Moaddel R; Laboratory of Clinical Investigation, National Institute on Aging Intramural Research Program, Baltimore, MD, 21224, USA., Morris PJ; National Center for Advancing Translational Sciences, Rockville, MD, 20850, USA., Shi L; Computational Chemistry and Molecular Biophysics Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA., Sibley DR; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, MD, 20814, USA., Mahler SV; Department of Neurobiology & Behavior, University of California, Irvine, CA, 92697, USA., Nabavi S; Department of Molecular Biology and Genetics, Dandrite, Aarhus University, 8000 Aarhus C, Aarhus, Denmark., Pomper MG; Department of Radiology Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA., Bonci A; Synaptic Plasticity Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA., Horti AG; Department of Radiology Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA. ahorti1@jhmi.edu., Richmond BJ; Laboratory of Neuropsychology, National Institute of Mental Health Intramural Research Program, Bethesda, MD, 20892, USA. barryrichmond@mail.nih.gov., Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA. mike.michaelides@nih.gov.; Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA. mike.michaelides@nih.gov.
Publikováno v:
Nature communications [Nat Commun] 2019 Oct 11; Vol. 10 (1), pp. 4627. Date of Electronic Publication: 2019 Oct 11.
Autor:
Slack RD; Molecular Targets and Medications Discovery Branch , National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health , 333 Cassell Drive , Baltimore , Maryland 21224 , United States., Abramyan AM; Molecular Targets and Medications Discovery Branch , National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health , 333 Cassell Drive , Baltimore , Maryland 21224 , United States., Tang H; Molecular Targets and Medications Discovery Branch , National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health , 333 Cassell Drive , Baltimore , Maryland 21224 , United States., Meena S; Department of Cellular and Molecular Physiology , Yale University School of Medicine , 333 Cedar Street , New Haven , Connecticut 06520 , United States., Davis BA; Department of Cellular and Molecular Physiology , Yale University School of Medicine , 333 Cedar Street , New Haven , Connecticut 06520 , United States., Bonifazi A; Molecular Targets and Medications Discovery Branch , National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health , 333 Cassell Drive , Baltimore , Maryland 21224 , United States., Giancola JB; Molecular Targets and Medications Discovery Branch , National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health , 333 Cassell Drive , Baltimore , Maryland 21224 , United States., Deschamps JR; Naval Research Laboratory , Code 6030, 4555 Overlook Avenue , Washington D. C. 20375 , United States., Naing S; Molecular Targets and Medications Discovery Branch , National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health , 333 Cassell Drive , Baltimore , Maryland 21224 , United States., Yano H; Molecular Targets and Medications Discovery Branch , National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health , 333 Cassell Drive , Baltimore , Maryland 21224 , United States., Singh SK; Department of Cellular and Molecular Physiology , Yale University School of Medicine , 333 Cedar Street , New Haven , Connecticut 06520 , United States., Newman AH; Molecular Targets and Medications Discovery Branch , National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health , 333 Cassell Drive , Baltimore , Maryland 21224 , United States., Shi L; Molecular Targets and Medications Discovery Branch , National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health , 333 Cassell Drive , Baltimore , Maryland 21224 , United States.
Publikováno v:
ACS chemical neuroscience [ACS Chem Neurosci] 2019 Sep 18; Vol. 10 (9), pp. 3946-3952. Date of Electronic Publication: 2019 Aug 22.
Autor:
Newman AH; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, USA. anewman@intra.nida.nih.gov., Cao J; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, USA., Keighron JD; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, USA., Jordan CJ; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, USA., Bi GH; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, USA., Liang Y; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, USA., Abramyan AM; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, USA., Avelar AJ; Department of Cellular and Integrative Physiology, UT Health Science Center, San Antonio, TX, USA., Tschumi CW; Department of Cellular and Integrative Physiology, UT Health Science Center, San Antonio, TX, USA.; Aging & Metabolism Research Group, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Beckstead MJ; Department of Cellular and Integrative Physiology, UT Health Science Center, San Antonio, TX, USA.; Aging & Metabolism Research Group, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Shi L; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, USA., Tanda G; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, USA., Xi ZX; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2019 Jul; Vol. 44 (8), pp. 1435-1444. Date of Electronic Publication: 2019 Mar 11.